Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K (Trevasc-HDK): A Study Protocol for a Randomized Controlled Trial

NCT02870829 is registered in ClinicalTrials.gov with National University Health System, Singapore as lead sponsor.

NCT NCT02870829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02870829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K (Trevasc-HDK): A Study Protocol for a Randomized Controlled Trial
Lead sponsor
National University Health System, Singapore
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2016
Completion date
February 28, 2022
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication of hemodialysis, deficiency of vitamin k2, systemic and arterial stiffness, vascular calcification